It's the inspiring story of a New Haven woman who had a double lung transplant, a journey that took her right by death's door.
US FDA approves Novartis drug Afinitor for breast cancer – Reuters
US FDA approves Novartis drug Afinitor for breast cancerReutersThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. The European Medicin…
Finally,Tibetan Dolma Bhutti can have kidney transplant – Indian Express
Finally,Tibetan Dolma Bhutti can have kidney transplantIndian ExpressFinally, there is good news for Tibetan national Dolma Bhutti. After a struggle for several months, her kidney transplant will be conducted. For, PGI and the Himachal Pradesh governme…
FDA approves Afinitor for advanced breast cancer – FDA.gov
FDA approves Afinitor for advanced breast cancerFDA.govThe U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor pos…
Few Hospitals Go the Distance to Reduce Readmissions for Heart Failure, AMI … – TCTMD
TCTMDFew Hospitals Go the Distance to Reduce Readmissions for Heart Failure, AMI …TCTMDThough most hospital administrators claim their institutions seek to reduce preventable readmissions for patients with heart failure or acute myocardial infarction…
FDA approves Novartis drug Afinitor for breast cancer – Reuters India
BloombergFDA approves Novartis drug Afinitor for breast cancerReuters IndiaThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. Afinitor…
Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a … – ITNews
Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a …ITNewsThe approval was based on a randomized, double-blind, placebo-controlled, multi- center trial called BOLERO-2 (Breast cancer trials of OraL EveROlimus-2), which eva…
Novartis gains FDA approval for AfinitorR in advanced breast cancer marking a … – Reuters (press release)
Novartis gains FDA approval for AfinitorR in advanced breast cancer marking a …Reuters (press release)Basel, July 20, 2012 – The US Food and Drug Administration (FDA) has approved Afinitor R (everolimus) tablets* for the treatment of postmenopausal w…
NOVARTIS AG : gains FDA approval for Afinitor® in advanced breast cancer … – 4-traders
NOVARTIS AG : gains FDA approval for Afinitor® in advanced breast cancer …4-tradersBasel, July 20, 2012 – The US Food and Drug Administration (FDA) has approved Afinitor ® (everolimus) tablets* for the treatment of postmenopausal women with advance…
Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a … – MarketWatch (press release)
Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a …MarketWatch (press release)Basel, July 20, 2012 – The US Food and Drug Administration (FDA) has approved Afinitor® (everolimus) tablets* for the treatment of postmenopau…